Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

News

Prenetics tests out $1.25bn reverse merger
Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Hydrogenious LOHC fuels up on funding
Erlangen-Nürnberg spinout Hydrogenious LOHC Technologies has added $59m to its coffers.
EnerVenue electrifies $100m series A
Stanford University has backed a round that will help the nickel-hydrogen battery developer finance construction of a Gigafactory.
Daily deal net: September 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Louisville launches UofL Ventures
Will Metcalf will lead the office, which will be located within University of Louisville’s Office of Research and Innovation.
Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Vanqua Bio wins over series B investors
Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.
AgBiome cultivates $116m series D
UNC Chapel Hill’s agricultural technology developer AgBiome has increased its overall funding to $230m following the series D round.

News Continued

Daily deal net: September 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
TreeFrog dives into $75m series B
The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.
Prospection delves into $33m series B
Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.
Georgia Tech selects Sivakumar
Raghupathy “Siva” Sivakumar has been appointed as the university’s inaugural vice-president of commercialisation and chief commercialisation officer.
Daily deal net: September 13, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Lexeo Therapeutics bags $100m
Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.

Editor's Picks

Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
O’Brien to lead Cambridge Enterprise
Diarmuid O’Brien will take over as chief executive of Cambridge Enterprise this September following the retirement of Tony Raven.
SETsquared portfolio to pitch at GCV Digital Forum
Four of the incubator’s portfolio companies will pitch to investors at the GCV Digital Forum 3.0 following the success of similar competitions at our previous events.
Raven reaches for next adventure
Tony Raven, CEO of Cambridge Enterprise and a GUV Lifetime Achievement awardee, will step down by the end of next year.
test reg

Login